In 2025, while the lithium industry remained in a low-growth phase, Tianqi Lithium Corporation delivered an annual report characterized by "revenue pressure but profit recovery." The company reported annual operating revenue of 10.346 billion yuan, a decrease of 20.80% year-on-year. However, it achieved a net profit attributable to shareholders of 463 million yuan, a significant turnaround from the substantial loss of 7.905 billion yuan in 2024. The net profit after deducting non-recurring items also returned to positive territory at 359 million yuan.
The profit recovery was notably back-loaded during the year. The company reported a net profit attributable to shareholders of 283 million yuan in the fourth quarter alone, accounting for over 60% of the full-year profit. The weighted average return on equity (ROE) improved to 1.10%, a marked recovery from the -16.92% recorded in 2024, though it still remains below the high profitability levels seen in 2023. The company's board proposed no cash dividend distribution, no bonus share issue, and no capital reserve conversion for the 2025 fiscal year. This decision reflects a conservative strategy focused on retaining sufficient cash reserves, as the company navigates a phase of profit recovery, capacity ramp-up, and variables related to its overseas interests.
**Performance: Revenue Continues Decline, Net Profit Turns Positive but Remains a "Low-Level Recovery"**
Key financial metrics disclosed in the annual report summary indicate that the theme for Tianqi Lithium in 2025 was "returning to profitability" but not a "strong recovery."
* Operating Revenue: 10.346 billion yuan (down 20.80% YoY; compared to 13.063 billion yuan in 2024 and 40.503 billion yuan in 2023) * Net Profit Attributable to Shareholders: 463 million yuan (compared to a loss of 7.905 billion yuan in 2024 and a profit of 7.297 billion yuan in 2023) * Net Profit After Deducting Non-Recurring Items: 359 million yuan (compared to a loss of 7.923 billion yuan in 2024) * Basic/Diluted Earnings Per Share: 0.28 yuan (compared to a loss per share of 4.82 yuan in 2024) * Weighted Average ROE: 1.10% (compared to -16.92% in 2024)
Against the backdrop of continued year-on-year revenue decline, the shift from a significant loss to a modest profit indicates that the primary challenge for profitability has transitioned from "loss elimination" to "verifying profit resilience and sustainability."
**Quarterly Performance: Fourth Quarter Leads the Recovery, Annual Profit Highly Concentrated**
The profit improvement was not evenly distributed across the quarters:
* Q1 Net Profit Attributable to Shareholders: 104 million yuan * Q2 Net Profit Attributable to Shareholders: -20 million yuan * Q3 Net Profit Attributable to Shareholders: 95 million yuan * Q4 Net Profit Attributable to Shareholders: 283 million yuan
The fourth quarter contributing over 60% of the annual profit highlights the operational improvement in the second half of the year. However, it also signals to investors that if fluctuations recur in industry pricing, utilization rates, or costs, profit volatility could correspondingly amplify.
**Capacity and Projects: Zhangjiagang 30k-ton Lithium Hydroxide Plant in Trial Operation, Talison Third-Stage Expansion Ramping Up**
In the midstream (lithium chemical) sector, the "30,000-ton annual battery-grade monohydrate lithium hydroxide project" at the Zhangjiagang base was a key growth driver in 2025:
* Total project investment does not exceed 2 billion yuan. * Construction was completed, and integrated trial operations began on July 30, 2025. * The first batch of products confirmed to meet battery-grade lithium hydroxide standards on October 17, 2025. * The facility possesses the capability for flexible switching to produce battery-grade lithium carbonate. * The company noted that the project has not yet reached full capacity and requires ongoing debugging and optimization.
In the upstream (lithium concentrate) sector, the third-stage chemical-grade lithium concentrate expansion project at the Greenbushes mine, associated with Talison, finally entered the production verification phase after delays:
* Construction was completed, and feed-in trial operations officially commenced on December 18, 2025. * The first batch of chemical-grade lithium concentrate meeting standards was produced on January 30, 2026. * Subsequent phases will focus on capacity ramp-up and stable production debugging.
From an investor's perspective, the key focus for both projects is not merely "whether they have commenced production," but rather the speed of the ramp-up, product yield rates, and the ability to achieve stable, continuous production. These factors will determine whether the projects can translate into sustainable shipments and cost advantages amidst industry fluctuations.
**Share Capital and Incentives: Repurchased Share Usage Adjusted and Cancelled, Impact Limited**
The company disclosed several adjustments to the use of shares repurchased in 2022: some were allocated for employee stock ownership plans and restricted stock incentives, while the remaining portion was ultimately designated for cancellation to reduce capital.
* The cancellation of 26,600 repurchased shares was completed in October 2025. * The cancellation amount was approximately 2.9879 million yuan. * Following the cancellation, the total number of shares decreased from 1,641,221,583 to 1,641,194,983.
The scale of this cancellation is minimal, having a limited impact on per-share metrics. It primarily represents a concluding step in the company's governance and incentive arrangements.
Comments